Software & Apps VC Funds

Jeito Capital is a global private equity fund specializing in life sciences, with a strong focus on biopharma companies. Founded in Paris, Jeito supports breakthrough innovations that address critical unmet medical needs. The fund's mission is centered on improving patient outcomes through targeted investments in early-stage and growth-stage biopharma companies, particularly those working on therapies for life-threatening diseases. Jeito operates with a unique long-term investment strategy, providing continuous financial support from clinical development through to market access. This allows its portfolio companies to achieve significant milestones while accelerating drug development. The fund has a diverse portfolio of companies, including SparingVision, which is developing gene therapy treatments for inherited retinal diseases, and CatalYm, a biopharma firm working on novel cancer immunotherapies. With over €534 million under management, Jeito's integrated team of experts spans the entire drug development value chain, offering portfolio companies not only capital but also strategic guidance in areas like regulatory affairs, clinical trials, and commercialization. Jeito’s investment approach is also distinguished by its emphasis on global impact, working across Europe and the United States to bring life-saving treatments to market. Jeito has rapidly become a significant player in the life sciences sector, driven by its patient-centered philosophy and focus on fostering the growth of biotech companies that are on the cutting edge of medical innovation.

Jerusalem Venture Partners (JVP), founded in 1993 by Dr. Erel Margalit, is a leading international venture capital firm headquartered in Jerusalem, with additional offices in New York, Tel Aviv, and Be’er Sheva. The firm focuses on early to growth-stage investments across various sectors including cybersecurity, big data, fintech, foodtech, and digital health. Notable investments by JVP include CyberArk, QlikTech, and Earnix. CyberArk is renowned for its cybersecurity solutions and went public on NASDAQ. QlikTech, a cloud-based business intelligence platform, also had a successful NASDAQ IPO. Earnix, which provides AI-based analytics solutions for insurers and banks, achieved unicorn status with its significant valuation. JVP has raised over $1.4 billion across multiple funds and has a strong track record of successful exits. The firm supports its portfolio companies through the Margalit Startup City model, which offers office space, management support, and strategic guidance in dynamic creative campuses located in Jerusalem and New York. These centers foster innovation and collaboration among startups, entrepreneurs, and strategic partners​.

JetBlue Ventures is dedicated to investing in early-stage startups that are transforming travel, hospitality, and transportation. Their primary focus areas include next-generation aviation operations, seamless customer journeys, innovative accommodations, loyalty and revenue optimization, and sustainable travel solutions. JetBlue Ventures aims to enhance the end-to-end travel experience and bring humanity back to travel on a grand scale. Their portfolio includes notable companies such as Joby Aviation, which is pioneering electric vertical takeoff and landing (eVTOL) aircraft, and Tomorrow.io, a weather technology company providing precise weather predictions to improve operational efficiencies in aviation. Other investments include FLYR, a SaaS platform for airline revenue management, and Transparent, a market intelligence company for vacation rentals​. JetBlue Ventures typically leads investment rounds and provides an average check size suited for early-stage funding. They also offer extensive support beyond financing, including community building, marketing assistance, business development, financial planning, and administrative support through their dedicated platform for portfolio companies​. The team, led by President Amy Burr, leverages deep expertise in aviation and hospitality, coupled with a strong focus on fostering innovation and helping startups scale. Burr's strategic direction has been pivotal in integrating successful startup programs into JetBlue's broader corporate innovation initiatives​.

Jets Capital is a UAE-based venture capital firm established in 2017, primarily investing in early-stage crypto and Web3 projects. With a focus on sectors such as blockchain infrastructure, decentralized finance (DeFi), Web2-to-Web3 transitions, decentralized autonomous organizations (DAOs), consumer applications, and GameFi, Jets Capital aims to support innovative startups that drive the integration of modern technologies into everyday life. The firm manages around $50 million and provides a comprehensive ecosystem to help startups scale, offering resources in areas like advertising, legal services, market entry, and strategic partnerships. Jets Capital positions itself as a long-term partner for startups, guiding them through the complexities of launching and growing in the blockchain and crypto space. Notable companies in its portfolio include Oasys, a blockchain project based in Singapore, where Jets Capital participated in a Series B round alongside other prominent investors. Led by CEO Sergei Khitrov, the team is composed of experienced professionals who focus on identifying early-stage projects with the potential to transform the digital economy. Although Jets Capital's recent activity indicates a slowdown in new investments, the firm remains a key player in the crypto venture capital landscape, particularly within the Middle Eastern market, where it aims to bridge technological innovation with scalable business models.

Jetstream is a venture capital firm based in San Francisco, specializing in early-stage investments in climate technology. Founded in 2018 by Tommy Leep, Jetstream focuses on pre-seed startups that are advancing sustainable solutions across various sectors including earth observation, clean energy, carbon removal, and forest conservation. Jetstream typically invests $250,000 in pre-seed climate tech software startups. The firm emphasizes a narrative-driven approach to help startups tell compelling stories that attract additional funding. Their investment strategy includes providing insider access to a network of key industry contacts and negotiation coaching to help startups secure favorable terms. Notable investments in Jetstream’s portfolio include Skydio, a leader in autonomous flight technology, and Beta Technologies, which develops electric vertical takeoff and landing (eVTOL) aircraft. The firm’s investment philosophy centers around creating impactful, scalable solutions that address critical environmental challenges. Jetstream's commitment to climate tech is further reflected in their annual UP.Summit, which gathers top innovators, investors, and corporate leaders to discuss and propel advancements in mobility and sustainability.

iangmen Ventures, established in 2015, is an early-stage venture capital firm based in Beijing, China. The firm focuses on investing in tech-driven startups, particularly those in sectors such as artificial intelligence, healthcare, IoT, and enterprise computing. Their strategy revolves around leveraging technological innovation to unlock business value, primarily targeting early-stage companies that show significant growth potential. Jiangmen has invested in over 50 startups across various industries, including notable companies like Hesai Technology and Heisenberg Robotics. The firm is known for its commitment to backing companies involved in frontier technology such as quantum computing, AI-powered platforms, and advanced manufacturing. One of its more recent investments includes MyTwins.ai, a Hangzhou-based AI platform. Co-founded by Vanessa Gao and Qiang Shen, Jiangmen Ventures takes a hands-on approach with portfolio companies, offering not only financial backing but also strategic mentorship to help startups scale effectively. The firm places a strong emphasis on innovative solutions that can disrupt traditional industries and foster industrial upgrades, particularly in China’s rapidly growing tech landscape.

Johnson & Johnson Innovation is a global network dedicated to empowering healthcare innovators. Founded in 2012, JLABS supports early-stage companies in the pharmaceutical, medical device, consumer, and health tech sectors. Their mission is to foster the development of life-saving and life-enhancing health solutions. JLABS operates across multiple locations, including San Diego, San Francisco, Cambridge, Shanghai, and New York. They offer a robust infrastructure and resources to startups, facilitating collaboration and growth. The initiative has made over 400 investments, including notable companies such as Capstan Therapeutics and Synthis Therapeutics, focusing on biotechnology and medical devices. Their investment strategy emphasizes strategic partnerships and co-investments, working alongside various industry leaders and funding bodies to maximize impact. Recent investments include support for companies like Immunyx, Grapheal, and Neurogene, showcasing their commitment to advancing innovative healthcare solutions.

JLL Spark Global Ventures is the corporate venture capital arm of JLL, focusing on strategic PropTech investments to drive innovation within the commercial real estate sector. Established in 2017, JLL Spark has invested over $390 million in more than 50 early-stage PropTech startups. These investments span various technologies, including IoT sensors, AI-driven platforms, and applications aimed at enhancing tenant experiences and building efficiencies. The team at JLL Spark, led by experienced professionals such as Raj Singh, Laurent Grill, and Mihir Shah, leverages JLL’s extensive real estate expertise and global network to support portfolio companies in scaling and entering new markets. JLL Spark's investment strategy emphasizes sustainability and the integration of AI to optimize real estate operations, reduce costs, and enhance environmental impact. Key portfolio companies include HqO, VergeSense, and Infogrid, which are transforming the way real estate operates through innovative technologies. JLL Spark’s approach involves not only providing capital but also ensuring that their portfolio companies are integrated into JLL’s business lines, creating synergies that drive growth and adoption of new technologies across the industry.

JME Venture Capital, established in 2009, is a prominent venture capital firm based in Madrid, Spain. It focuses on early-stage technology startups, investing primarily in Spanish companies with notable expansions across Europe and occasional investments in the US. The firm has raised three funds with over €120 million in assets under management (AUM), investing between €100k and €3m per deal. JME's investment portfolio includes successful companies like Flywire, Jobandtalent, and Voi. Their investment strategy targets sectors such as fintech, healthtech, and blockchain technology. Notably, JME has invested in over 70 startups, leading to significant exits including companies like Volava and Waynabox. The team at JME Venture Capital is led by Samuel Gil and Javier Alarcó, who emphasize a fast and transparent investment process. They support founders with global-scale resources while allowing them to maintain control over their vision and operations​.

Join Capital is a Berlin-based venture capital firm specializing in early-stage investments in deep tech and industrial tech startups. They focus on sectors such as manufacturing, construction, logistics, and enterprise software. Their investment strategy emphasizes helping European deep tech startups achieve significant growth and traction. Join Capital provides not only financial backing but also extensive support through their 360-degree support series, which includes talent selection, sales development, and strategic alignment. Some of their notable investments include Frenetic, a company pioneering custom magnetics technology, and Generative Engineering, which aims to revolutionize physical engineering processes. These investments reflect Join Capital's commitment to backing innovative solutions that address complex industrial challenges. Join Capital is led by a team of experienced professionals who bring a wealth of knowledge in both technical and business fields. This combination enables them to effectively mentor and support startups from inception to market leadership. The firm’s approach is highly collaborative, working closely with founders to transform technical expertise into successful business ventures. For startups looking to engage with Join Capital, it's crucial to present innovative deep tech solutions with clear potential for industrial application and scalability. The firm values strong technical foundations paired with a vision for significant market impact.

Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson, focused on investing across the healthcare spectrum. Established in 1973, it is one of the longest-standing corporate venture firms, with a mission to drive transformative innovations that address critical healthcare needs. JJDC invests globally across sectors like biotechnology, pharmaceuticals, medical devices, health tech, and digital health, often aligning its investments with Johnson & Johnson's core business areas. The firm has regional innovation centers in Boston, Menlo Park, London, and Shanghai, allowing it to stay close to emerging trends and collaborate with startups at various stages, from seed to later-stage rounds. JJDC's portfolio includes companies like Genmab, Vedanta Biosciences, and Bright Peak Therapeutics, reflecting its focus on breakthrough therapies and next-gen healthcare solutions. Additionally, JJDC leverages Johnson & Johnson’s extensive resources, providing not only capital but also strategic support, including R&D, regulatory guidance, and commercialization pathways. The investment approach of JJDC prioritizes long-term strategic value over immediate returns. This allows it to support ventures through the often lengthy development timelines typical of the healthcare industry, ultimately aiming to integrate successful innovations into Johnson & Johnson’s ecosystem. With a legacy of fostering groundbreaking medical technologies, JJDC remains committed to advancing patient care globally while continuing to evolve alongside the dynamic healthcare landscape.

Jolt Capital is a Paris-based private equity firm specializing in growth-stage investments in deeptech companies across Europe. Founded in 2011, Jolt focuses on supporting technology-rich firms with strong fundamentals, particularly in sectors like photonics, advanced materials, semiconductors, artificial intelligence, and IoT. They typically invest between €10 million and €50 million in businesses that are poised for significant scale, offering both capital and operational expertise to help them expand globally. Jolt Capital stands out by using its proprietary AI platform, Jolt.Ninja, to identify promising investment opportunities. This technology-driven approach allows the firm to discover high-potential companies while avoiding market hype. Their portfolio includes notable companies like Heptagon, NIL Technology, and Verimatrix, all of which leverage cutting-edge technology to address significant market needs. The team at Jolt Capital combines decades of experience in technology, investment, and entrepreneurship, working hands-on with portfolio companies to assist in everything from business strategy to talent acquisition and financial optimization. With a focus on sustainable and responsible investment, Jolt Capital’s mission is to grow European deeptech firms that can transform industries and improve societal outcomes.

Joule Ventures, formerly known as Janvest Capital Partners, is a U.S.-based seed fund focused on investing in Israeli founders who are commercializing enterprise-grade solutions for the U.S. market. The firm, which recently closed a $65 million Fund IV, operates from offices in Tel Aviv, New York, and Atlanta. The firm emphasizes hands-on, high-conviction investments in pre-seed and seed stage companies, particularly in sectors like cybersecurity, AI/ML, fintech, DevOps, data enablement, and software. Notable investments include BioCatch, a leader in behavioral biometrics, and Coralogix, a company providing full-stack observability solutions. Joule Ventures has also backed emerging companies such as Mirato, an AI-driven TPRM platform for financial institutions, and Arnica, a stealth-mode DevSecOps startup. Joule Ventures stands out for its comprehensive support system, offering U.S. market validation, design partner engagement, early customer connections, core team recruitment, cap table and corporate governance guidance, Series A acceleration, and branding and PR support. This extensive involvement helps ensure that their portfolio companies are well-equipped for success in the competitive U.S. enterprise market​.

Joules Accelerator, based in Charlotte, North Carolina, is a non-profit organization dedicated to supporting early-stage climate tech startups. Since its founding in 2013, Joules has been at the forefront of promoting innovative solutions in climate and energy, particularly in the Southeast region of the United States. Joules Accelerator runs two 90-day cohorts per year, each consisting of 6-10 startups. These cohorts focus on technologies that drive decarbonization and electrification. The accelerator provides startups with access to a vast network of industry advisors and partners, including Duke Energy, Microsoft, and EY. Startups are offered opportunities for revenue-generating pilots, commercialization, and strategic connections within the industry. The program is highly selective, conducting due diligence on hundreds of startups to choose the best candidates. Startups benefit from mentoring, networking, and the potential to receive Joules Camp pilot grants ranging from $10,000 to $20,000 to deploy their technologies in underserved communities across the Carolinas. Joules has successfully supported numerous startups. For instance, Harvest, a graduate from one of their cohorts, recently closed a $4.2 million seed round and won the CEE Integrated Home Competition. Another notable alumni, Rhizome, secured $2.5 million in venture capital and expanded its customer base to several major electric utilities. The accelerator emphasizes values such as diversity, equity, inclusion, transparency, and integrity, ensuring that their work positively impacts both startups and the broader community.

Jovono Ventures, based in Los Angeles and founded in 2016, is a venture capital firm that focuses on investing in paradigm-shifting companies and missionary founders who tackle hard problems or create delightful products. Their portfolio reflects a diverse range of industries, particularly high-tech and enterprise applications. Some of Jovono's notable investments include Anduril Industries, a provider of AI-based defense solutions; Flexport, a digital freight forwarding platform; and DoNotPay, a legal tech company that helps users navigate legal paperwork. Other significant investments are in companies like Sofar Ocean Technologies, QEDIT, and Paragon​. Jovono's investment strategy does not limit itself to specific stages, locations, or industries, but rather focuses on the potential impact and innovation of the companies. This flexibility allows them to back transformative startups at various stages of development. They have made 23 investments so far, including in early-stage companies such as Persist AI and Apollo Brokers. The firm is led by Evan Zimmerman, who brings extensive experience and a strong vision for supporting groundbreaking ventures. Jovono's commitment to building long-term partnerships with founders and helping them navigate their growth journeys sets it apart in the venture capital landscape.

Joy Ventures, now rebranded as Corundum Neuroscience, is a venture capital firm originally founded in 2017 and based in Herzliya, Israel. The firm has transitioned its focus to become a neuroscience-focused venture builder and fund. Under its new identity, Corundum Neuroscience aims to drive innovation in neuroscience by investing in and supporting early-stage companies that develop groundbreaking consumer products and technologies rooted in scientific research. The firm specializes in nurturing startups at various stages, from seeding ideas to advancing them through the critical phases of development. Corundum Neuroscience emphasizes creating products that enhance emotional and mental well-being, reflecting its deep commitment to improving human health through innovative technologies. The firm’s strategy includes providing not just financial backing but also extensive resources such as mentorship, strategic guidance, and access to a network of experts in neuroscience and related fields. With its rebranding, Corundum Neuroscience is positioned to become a leader in the neuroscience sector, fostering the development of cutting-edge solutions that address some of the most pressing challenges in mental health and cognitive sciences.

Joyance Partners, established in 2017, is a venture capital firm based in San Francisco, California. The firm focuses on investing in early-stage companies that use science and technology to cultivate joy, aiming to improve the way we live. Joyance Partners has made significant investments in health and consumer sectors, targeting companies from pre-seed to Series A stages across North America, Europe, and Asia. Their notable investments include ClosedLoop, which uses AI to identify at-risk patients and recommend interventions, and Copper Cow Coffee, which delivers a premium Vietnamese coffee experience. Another standout is Cubby, which creates smart beds designed to improve anxiety, sleep, and safety for individuals with cognitive disabilities such as Autism and Epilepsy. Joyance Partners also backs innovative companies in beauty and sustainability, like Conserving Beauty, which focuses on solutions-based skincare, and Electric Era, which works on sustainable energy solutions. The firm has made over 500 investments and boasts more than 200 exits, reflecting a strong track record in nurturing and scaling startups. They support companies that promise to enhance personal health, happiness, and well-being through technological advancements. The leadership team, including Managing Partner Michael Edelhart and Founding Partner William Lohse, leverages their extensive experience to guide their portfolio companies towards growth and success. Joyance Partners continues to be an influential player in the venture capital landscape, dedicated to investing in transformative technologies that bring joy to people's lives​.

The Joint Polish Investment Fund (JPIF) is a venture capital firm based in Warsaw, Poland, established in 2015. The fund primarily focuses on investments in life sciences, targeting early-stage and mid-stage companies, particularly those with clear and near-term value inflection points. JPIF typically holds investments for a period of 3-5 years, aiming to achieve significant growth and value creation during that time. The fund has a specific interest in sectors such as therapeutic devices, monitoring equipment, and personalized medicine, with investments made in companies like Fixnip and DreamJay. JPIF's strategy involves not only providing financial support but also leveraging its team's extensive experience in the life sciences to guide these companies towards successful commercialization. JPIF is led by Kreske Nickelsen, the CEO, along with a team of general partners who bring diverse expertise to the fund's operations. The firm operates under the broader European venture capital landscape, contributing to the growth of innovative life science companies in Central and Eastern Europe.

JSR Corporation, headquartered in Tokyo, Japan, is a multinational company specializing in digital solutions, life sciences, and elastomers. Founded in 1957, JSR initially focused on synthetic rubbers but has since expanded its operations to become a leading global supplier in various technology-driven markets. One of JSR's major areas of expertise is semiconductor materials, where they produce lithography materials, CMP materials, and packaging solutions essential for semiconductor chip production. The company has also made significant strides in the life sciences sector, providing services and materials for drug discovery, diagnostics, and bioprocessing. They acquired companies like KBI Biopharma and Selexis to strengthen their capabilities in this field. JSR is also heavily involved in advanced semiconductor technologies. They acquired Inpria Corporation, a leader in metal oxide photoresist technology for extreme ultraviolet (EUV) lithography, to bolster their semiconductor materials portfolio. This acquisition aligns with JSR's strategy to enhance their presence in advanced semiconductor manufacturing processes. Moreover, JSR collaborates with Cambridge Quantum Computing (CQC) on quantum computing projects to develop state-of-the-art quantum algorithms. This partnership highlights JSR's commitment to staying at the forefront of technological innovation. Overall, JSR Corporation leverages its extensive R&D capabilities and strategic acquisitions to maintain its leadership in the semiconductor and life sciences industries, continuously driving innovation and value creation for its global customers.

Jump Capital is a Chicago-based venture capital firm that specializes in early to growth-stage investments, focusing on sectors like fintech, data infrastructure, B2B SaaS, and crypto. Established in 2012, Jump adopts a thesis-led approach, allowing it to dig deep into specific sectors and back founders who align with its vision of technological transformation. The firm typically invests between $2 million and $20 million, often at Series A and B stages, and is known for providing hands-on operational support beyond just capital. Their portfolio includes high-profile companies such as M1 Finance, TradingView, Bitpanda, and TubiTV, with over 100 investments and 30 successful exits to date. Jump Capital has established a reputation for leveraging its extensive operating backgrounds and strategic expertise to help startups scale, while also maintaining a strong focus on the evolving crypto space, which has become a core part of their investment strategy. The firm primarily targets startups across the U.S., especially those outside traditional coastal hubs, and has been a driving force behind companies pushing boundaries in their respective industries.

Jump Crypto, the blockchain and crypto division of Jump Trading Group, was established to drive innovation in the decentralized finance (DeFi) and Web3 ecosystems. Launched in 2015, it has grown into a major player in the blockchain space, focused on building essential infrastructure for public blockchain networks. The team at Jump Crypto includes developers, engineers, and traders who work to develop cutting-edge solutions for the decentralized future. The firm is particularly well-known for its contributions to projects like Wormhole, a decentralized cross-chain messaging protocol, and Serum, an on-chain exchange built on the Solana blockchain. Their work on Firedancer, a new validator client for Solana, exemplifies their dedication to improving the performance, resilience, and scalability of blockchain systems. Jump Crypto actively invests in early-stage blockchain projects, with significant capital deployed across the ecosystem. It operates globally, with a team of over 80 people and billions of dollars in investments across crypto and DeFi projects. The firm plays a key role in providing liquidity to markets while also contributing to the development of decentralized applications (dApps). Jump Crypto’s long-term vision is to create the infrastructure needed to support open, community-driven networks. Their hands-on approach, combined with their deep understanding of both traditional and decentralized markets, positions them as a leader in the crypto space.

Jumpstart Foundry (JSF) is a Nashville-based pre-seed healthcare innovation fund dedicated to supporting early-stage healthcare startups across the United States. Since its inception, JSF has become one of the most active funds of its kind, making around 35-40 investments annually. The fund primarily focuses on healthcare IT, consumer health products, tech-enabled services, and diagnostic devices, but avoids investing in biotechnology, pharmaceuticals, and life sciences. JSF’s investment model is built around providing strategic capital through a standardized investment structure. Typically, they offer $150,000 via a SAFE (Simple Agreement for Future Equity) note, which helps startups avoid complex negotiations and legal fees. Additionally, companies that receive funding from JSF gain access to the Jumpstart Insight program, which includes strategic resources, leadership training, and networking opportunities designed to support startup growth. Headquartered in Nashville, JSF maintains a broad reach, supporting companies nationwide and seeking founders who demonstrate market validation and early traction. The fund recently launched its ninth publicly-marketed fund under the 506(c) status, allowing it to attract more investors through platforms like AngelList Venture. This shift has opened new opportunities for accredited investors looking to back innovative healthcare solutions. With a commitment to scaling healthcare innovations and lowering barriers to entry, JSF continues to play a vital role in nurturing early-stage companies, providing not just capital, but also the resources and connections needed to drive transformative change in the healthcare industry.

Jumpstart Nova, launched in 2022 with an oversubscribed $55 million fund, is the first venture capital fund exclusively focused on Black-founded and Black-led healthcare companies in the U.S. Based in Nashville and Los Angeles, the fund targets seed and Series A startups in sectors such as health IT, digital health, biotech, diagnostic devices, and tech-enabled healthcare services. Led by founder Marcus Whitney, the fund addresses the long-standing gap in venture capital allocation to Black innovators, with a mission to drive equity in healthcare innovation. Jumpstart Nova’s portfolio includes companies like Alerje, a food allergy management startup, and Cellevolve, a biotech firm focused on cell therapy advancements. The firm is backed by major healthcare institutions including Eli Lilly, HCA Healthcare, and the American Hospital Association, which provide strategic support alongside capital. With a strong focus on fostering both company and leadership development, Jumpstart Nova is more than just a financial investor. The team, which includes partner Kathryne Cooper, works closely with founders, helping them navigate challenges and scale their businesses. Entrepreneurs backed by Jumpstart Nova benefit from their extensive network and industry expertise, ensuring that innovative healthcare solutions from underrepresented groups can thrive.

Junction Growth Investors, based in Antwerp, Belgium, is a growth equity firm established in 2022 with a strong focus on energy transition. The firm is dedicated to supporting small and medium-sized enterprises (SMEs) that work on clean technology and renewable energy solutions. Their primary goal is to scale innovations that significantly reduce greenhouse gas emissions, aligning with both the Paris Agreement and the EU's Green Deal goals of net-zero emissions by 2050. Junction's investment strategy targets later-stage companies that have proven products and are generating revenue. They typically invest between €2 million and €15 million in Series C and beyond, seeking businesses that can make a substantial impact in the energy and climate tech sectors. Recent investments include companies such as Eneida, Ampacimon, and EET. The team is composed of experienced entrepreneurs and professionals with a proven track record in reducing CO2 emissions through successful energy projects. They work closely with founders to navigate the complexities of scaling climate-focused innovations across Western Europe. For startups, demonstrating strong revenue growth and a direct contribution to a low-carbon future is essential to attract their attention.

Jungle Ventures, based in Singapore, is a prominent venture capital firm specializing in early to growth-stage investments across Southeast Asia and India. Established in 2012 by Amit Anand and Anurag Srivastava, the firm has over $1 billion in assets under management and a robust portfolio of companies. Notable investments include Kredivo, a leading digital lending platform in Southeast Asia; Livspace, a platform offering home renovation and interior design services; Moglix, a B2B e-commerce platform for industrial goods; Turtlemint, an insurance technology company facilitating financial advisory services; and Sociolla, a comprehensive beauty and personal care platform. Jungle Ventures focuses on consumer, B2B, and software tech businesses, providing significant capital and strategic support from seed to exit. Their investment strategy includes participating in various funding rounds, often leading or co-leading investments ranging from $500,000 to $20 million, and reserving follow-on capital for further growth. The firm prides itself on deep market knowledge, strong industry relationships, and a collaborative approach, aiding startups in scaling sustainably and reaching global markets.

Juvo Ventures is a mission-driven venture capital firm focused on early-stage, technology-enabled education companies. Founded to empower entrepreneurs who are transforming education, Juvo invests in businesses that improve access, quality, and outcomes across the education-to-work pipeline. The firm’s name, "Juvo," meaning "to help" in Latin, reflects its goal of supporting innovative solutions that enhance learning from early childhood to adulthood. Juvo takes a double-bottom-line approach, seeking both financial returns and meaningful social impact. Its portfolio includes companies like VictoryXR, a leader in immersive learning and "metaversities," Kenzie Academy, which prepares learners for tech careers, and SchooLinks, which helps transform school districts into talent pipelines. Juvo’s investments focus on scaling education technologies that make learning more accessible and adaptable for all. Through partnerships with these innovative companies, Juvo Ventures is actively contributing to better education outcomes, while also addressing critical issues like diversity and inclusion. Their investments align with global goals for sustainable development and offer transformative solutions for both learners and educators alike.

Juxtapose is a New York-based venture studio that takes a unique approach to building and funding companies. Founded in 2015 by Patrick Chun and Jed Cairo, the firm specializes in creating businesses from scratch, focusing on underserved markets where they can make a transformative impact. Juxtapose conducts extensive market research to identify opportunities, then develops the business concept, recruits founding CEOs, and provides both capital and operational support to bring these ideas to life. The firm operates more like a blend of venture capital and private equity, combining the agility of startups with the structured approach of larger buyouts. This strategy has led to successful ventures like Tend, a modern dentistry chain, and Orchard, a real estate platform that simplifies the home buying and selling process. They recently raised $300 million for their second fund to continue scaling their business-building model, aiming for VC-level returns but with the lower risks associated with PE-style management and oversight. Juxtapose’s portfolio spans various industries, including healthcare, real estate, and financial services, with a focus on enhancing consumer experiences. The firm's philosophy emphasizes strategic alignment between investors, management, and other stakeholders to build long-term value. Their approach to innovation and commitment to operational excellence makes them a standout player in the venture studio space.

K Fund is a venture capital firm based in Madrid, Spain, focused on backing tech-driven startups across Southern Europe and Latin America. Founded in 2016, K Fund invests from pre-seed to Series B stages, with check sizes ranging from €100K to €10 million. Their mission is to support visionary, unconventional entrepreneurs who are building scalable, technology-based solutions. The firm’s portfolio includes successful ventures such as Factorial, Exoticca, Voicemod, and Urbanitae, reflecting a diverse range of sectors including SaaS, fintech, travel, and AI. K Fund recently expanded its global footprint by establishing a local presence in São Paulo, Brazil, through their Leadwind fund. This initiative, launched with strategic partners like Telefónica and BBVA, targets deep tech scaleups and aims to bridge the startup ecosystems of Southern Europe and Latin America. Leadwind focuses on sectors like AI, IoT, and blockchain, with the goal of fostering collaboration between these two regions. The fund plans to raise €250 million, making investments starting at €5 million, to help scale these innovative businesses globally. K Fund also emphasizes ESG principles, recently publishing their first impact report, and has committed to promoting sustainability and diversity within their portfolio. Led by a team of seasoned professionals including Miguel Arias and Gustavo S. Carvalhal Ribas, K Fund continues to grow its influence, supporting startups that aim to disrupt traditional markets with cutting-edge technology and scalable business models.

K11 is a unique venture led by Adrian Cheng that blends art, culture, and retail through its K11 Musea and K11 Art Mall projects. These initiatives reflect a pioneering approach to cultural commerce, integrating art and innovation into consumer experiences. K11 Musea, located in Hong Kong, is a prime example, combining retail with museum-level art exhibitions and design. In terms of investments, K11 focuses on innovative projects that align with its ethos of blending art and commerce. Its investment arm has backed companies in technology, culture, and real estate, looking for ventures that promote sustainability and cultural relevance. K11 has invested in companies like Ping An Technology, reflecting its interest in merging tech with everyday experiences. The group is expanding its footprint globally, making strategic investments to enhance both cultural impact and economic growth. K11’s mission revolves around creating “a museum-retail experience,” which sets it apart from traditional investors by emphasizing both cultural enrichment and commercial success in its projects. Through its investments, K11 supports ventures that create immersive consumer experiences while driving innovation across sectors.

K5 Global is a venture capital firm and incubation studio founded in 2018 by Michael Kives and Bryan Baum. Based in San Francisco, the firm supports founders throughout the entire business lifecycle, from seed stages to IPOs. K5 Global has deployed over $1.1 billion in capital and has made 174 direct investments, resulting in 11 exits. Their portfolio includes high-profile companies such as SpaceX, Uber, Coinbase, Lyft, and The Boring Company. K5 Global focuses on a wide array of industries, including enterprise SaaS, vertical SaaS, fintech, and consumer products. Some notable investments and launched companies include 818 Tequila, Parrot, and The Expert. The firm leverages its extensive network to help innovative companies expand and achieve their growth targets. The management team, led by Michael Kives and Bryan Baum, brings a wealth of experience from various sectors, ensuring robust support for their portfolio companies. K5 Global continues to make significant investments in cutting-edge technologies and groundbreaking startups​.

K50 Ventures, established in 2017 and headquartered in New York, is a venture capital firm dedicated to funding purpose-driven companies at the pre-seed and seed stages. The firm focuses on startups that aim to improve access and affordability in health, finance, and work for the global working class. Notable investments include Mammoth Biosciences, a pioneer in CRISPR technology; Groww, a mobile investing platform in India; and Midi Health, providing specialized healthcare for women over 40. K50 Ventures supports companies that democratize access to financial services, improve healthcare delivery, and empower small businesses and independent workers. Led by founders Ryan Bloomer and Adriel Bercow, K50 Ventures is committed to being the first institutional check and a long-term partner to mission-driven entrepreneurs. They seek founders with a clear vision for creating significant social impact and a solid strategy for execution.

K9 Ventures is a technology-focused venture capital firm based in Palo Alto, California. It specializes in pre-seed investments, typically engaging with companies at their earliest stages of development. Founded by Manu Kumar, K9 Ventures aims to be the first institutional capital for startups, often leading investment rounds and taking an active role in company development. K9 Ventures has a diverse portfolio, with notable investments including companies like Twilio, Carta, and Lyft. These companies have seen significant growth and success, with Twilio and Lyft going public and Carta becoming a unicorn. Other significant investments include Auth0, which provides identity and access management solutions and was acquired by Okta, and Osmo, an educational game developer acquired by Byju's. The firm's investment strategy involves initial investments ranging from $250K to $750K, focusing on leading rounds and actively working with founders. K9 Ventures typically invests in 4-6 companies per year, allowing for deep engagement with each portfolio company. Their investment approach is characterized by a commitment to transparency, respect, honesty, and humility, aiming to build long-term relationships with founders and help them navigate various challenges from product development to marketing and fundraising. K9 Ventures' portfolio highlights their focus on innovative technology and their role in helping startups achieve significant milestones and exits. For more details, you can explore their investments and approach on their official website.

Kae Capital is a prominent early-stage venture capital firm based in Mumbai and Bengaluru, India. Founded in 2012 by Sasha Mirchandani, the firm focuses on investing in pre-seed to pre-series A startups across a variety of sectors, including e-commerce, SaaS, fintech, healthtech, consumer internet, and more. Known for being sector-agnostic, Kae Capital partners with passionate founders to build scalable businesses for both Indian and global markets. Kae Capital has built a strong portfolio, with notable investments in companies like Zetwerk, HealthKart, 1mg, and LoanTap. The firm typically makes seed investments in the range of $1 million, with follow-on rounds in subsequent stages. Their strategy revolves around supporting founders through various growth stages, offering not just financial backing but also operational support, network access, and strategic guidance to help startups find product-market fit and scale effectively. The firm is deeply committed to fostering long-term relationships with founders, with a philosophy centered on being an "all-weather partner." This approach ensures that Kae stays by the side of its portfolio companies during both high-growth phases and challenging times, providing consistent support. With over a decade of experience in early-stage investing, Kae Capital is recognized as a key player in India’s startup ecosystem.

Kairos HQ, founded in 2008 by Ankur Jain, is a venture capital firm based in New York City. Initially launched as The Kairos Society, it aimed to address significant global challenges through innovation. The firm focuses on early to mid-stage investments in healthcare, financial services, and consumer goods sectors, emphasizing affordability and simplicity in everyday life​. Notable investments include Bilt Rewards, a program allowing renters to earn points with rent payments, and Clair, which raised $25 million in its Series A round in July 2023. Other significant investments are Cera Care, a UK-based homecare service, and Alloy Health, a company focused on menopause health. Kairos HQ's strategy leverages its extensive network and expertise in building companies that tackle real-world problems. They manage around $300 million in assets, investing in startups that aim to improve housing affordability and personal health. The leadership team includes Co-CEOs Ankur Jain and Alex Fiance, and they emphasize a hands-on approach to nurturing their portfolio companies, providing strategic guidance and operational support to drive growth and success​.

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.

Kaiser Permanente Ventures (KP Ventures) is a leading venture capital firm dedicated to investing in innovative healthcare solutions. Founded in 1998, KP Ventures has over $500 million in assets under management and focuses on areas such as health information technology, digital health, medical devices, diagnostics, and precision medicine. KP Ventures recently closed its fifth fund at $141 million, which includes contributions from Kaiser Permanente as well as other strategic investors like Tufts Health Plan, Henry Ford Health System, and Highmark Ventures. The firm's investment strategy aims to support companies that address significant unmet needs in the healthcare system, particularly those that align with Kaiser Permanente's mission of providing high-quality, affordable, and accessible care​. Some notable companies in their portfolio include iRhythm, Health Catalyst, and Omada Health. KP Ventures leverages its deep connections with Kaiser Permanente and other healthcare leaders to help its portfolio companies navigate and thrive in the complex healthcare landscape. The team at KP Ventures comprises experienced professionals like Cindy Vanderlinde-Kopper, Amy Belt Raimundo, and co-founders Chris Grant and Chris Stenzel, who bring extensive expertise in healthcare and venture investing.

Kakao Ventures, founded in 2012, is a premier venture capital firm based in Seongnam-si, South Korea. As an independent subsidiary of Kakao Corp., it focuses on seed to growth-stage investments, primarily targeting tech-enabled startups in sectors like enterprise software, productivity tools, SaaS, and gaming. The firm has a notable portfolio, including successful investments in companies such as Lunit, an AI-powered medical imaging company; Dable, a content discovery platform; and Kids Note, an app for parent-teacher communication. Kakao Ventures manages several funds, emphasizing a founder-friendly approach that offers substantial support beyond capital. The firm aims to foster innovation and growth in the tech ecosystem by providing strategic guidance, mentorship, and networking opportunities to its portfolio companies. This comprehensive support system has enabled many startups to scale successfully and achieve significant market positions. With a strong commitment to driving technological advancement, Kakao Ventures actively seeks out innovative solutions that have the potential to disrupt industries and improve lives. The firm’s investment strategy focuses on identifying and nurturing early-stage companies with high growth potential, ensuring they have the resources and expertise needed to thrive in competitive markets. Kakao Ventures’ team comprises experienced professionals with deep industry knowledge and a passion for entrepreneurship. This combination of expertise and dedication has established the firm as a key player in the venture capital landscape, contributing to the growth and success of Korea’s tech startup ecosystem.

Kalei Ventures, founded in 2019 and headquartered in Buenos Aires, Argentina, is a venture capital firm focused on early-stage investments in Latin America. The firm aims to support outstanding entrepreneurs building global category leaders within the region. Kalei Ventures invests primarily in sectors such as fintech, e-commerce, logistics, marketplaces, entertainment, education, and B2B SaaS. Notable investments by Kalei Ventures include BrainLogic AI, a company specializing in artificial intelligence, and Moova, a logistics technology firm. The firm also backs startups like AgroForte, which focuses on financial software for agriculture, and Elery, which provides outpatient services technology. These investments highlight Kalei Ventures' dedication to fostering innovation and growth in diverse industries across Latin America. Kalei Ventures' team comprises experienced partners like Leandro Pisaroni Gerbaldo, Pablo Gutierrez Oyhanarte, and Tomás Braun, who leverage their deep industry knowledge and networks to support portfolio companies. The firm is committed to identifying and nurturing high-potential startups, facilitating their expansion and success on a global scale.

Kapor Capital, based in Oakland, California, is renowned for its commitment to investing in early-stage tech startups that drive social impact and economic equity. Their portfolio includes notable startups like Bitly, Life360, and AngelList, reflecting their diverse investment range across sectors such as education, health, finance, and justice. Kapor Capital specifically targets tech-driven ventures that aim to close gaps in access for low-income communities and communities of color. Geographically, Kapor Capital focuses primarily on the United States, with a significant presence in the Bay Area. Their investment strategy emphasizes backing founders who leverage their lived experiences to address real community needs. The firm has a robust investment strategy, often leading funding rounds with average check sizes typically between $500,000 and $1 million. They are known for their active involvement in their portfolio companies, providing extensive support beyond capital, including strategic guidance and fostering a dynamic ecosystem for innovation. The fund prides itself on a rigorous commitment to diversity, with a significant portion of their investments going to companies with underrepresented and women founders. In 2023 alone, they deployed $10.7 million across 19 companies, demonstrating their active investment approach. Founders can approach Kapor Capital through their Platform team, which curates events and builds networks to support portfolio companies. Key team members include Mitch Kapor and Freada Kapor Klein, who bring decades of experience in tech and social impact investing. Their leadership has been pivotal in shaping the firm’s mission-driven approach. With a deep commitment to creating a fairer society, Kapor Capital continues to lead the way in impact investing.

Karista is an early-stage venture capital firm based in Paris, specializing in Health, Digital, Technology, and NewSpace sectors. Founded in 2001, the firm has backed over 100 companies, providing more than just financial support. Karista is known for its hands-on approach, helping startups with team structuring, business development, and strategic guidance. Notable investments include Exotrail, a company developing agile space mobility solutions, and Incepto, which raised €27M for its digital health platform. Karista typically invests between €500k and €2.5M in seed and Series A rounds, with follow-on investments up to €6M. They often take board seats to offer deep involvement in the companies they support. Karista's strategy emphasizes early investment in innovative projects with strong value propositions. They co-create with founders, ensuring alignment in vision and goals. The firm manages several funds, including the Paris Region Venture Fund and the SpaceTech fund, focusing on companies ready to impact their markets and improve user lives.

Karlin Ventures is a Los Angeles-based early-stage venture capital firm that operates as an affiliate of Karlin Asset Management, which manages over $1.4 billion in unleveraged equity. Founded in 2013, the firm focuses on supporting entrepreneurs who take bold, contrarian approaches to solving complex problems. Karlin Ventures primarily invests in enterprise software, e-commerce, marketplaces, advertising technology, and education technology, but remains open to disruptive ideas across other verticals. Their investment strategy revolves around early-stage funding, with typical investments ranging from $100,000 to $2 million. Karlin Ventures prefers to co-invest alongside other firms and actively participates in follow-on rounds, adding value through mentorship and operational guidance. Notable portfolio companies include Policygenius, ChowNow, and ShipHawk, covering industries such as logistics, healthcare, and insurtech. Karlin Ventures’ geographic focus is primarily the U.S., where they partner with founders to scale their solutions, often emphasizing markets that require impactful, technology-driven innovations. The firm is known for providing more than just capital, fostering long-term relationships with founders by leveraging deep industry expertise and strategic support.

Karma Ventures is an early-stage venture capital firm based in Tallinn, Estonia, specializing in late seed and Series A investments in Europe's deep-tech software startups. Founded in 2016 by Margus Uudam and Tommi Uhari, the firm focuses on companies with strong technological innovation, initial commercial traction, and global ambitions. Notable investments by Karma Ventures include Wirepas, an industrial IoT company; Tuum (formerly Modularbank), a fintech platform; Lucinity, an AI-driven anti-money laundering platform; and BforeAI, a network management software company. These investments highlight the firm's commitment to backing startups with unique technologies and significant market potential. Karma Ventures typically invests up to EUR 5 million per company and continues to support them through follow-on investments in later rounds. The firm's portfolio also includes companies like Sonarworks, MeetFrank, and Xolo, further showcasing its focus on diverse technological innovations. The firm operates with a hands-on approach, providing strategic, commercial, and technical support to help startups navigate their growth paths. Karma Ventures leverages the expertise of its partners and advisors, including notable figures like Ahti Heinla, co-founder of Skype and Starship Technologies, and Sergei Anikin, former CTO of Pipedrive.

Karman Ventures, formerly known as Moving Capital, is a venture capital firm co-founded by early Uber employees. Based in the United States, Karman primarily focuses on investing in innovative, tech-driven startups across various sectors, including transportation, aerospace, fintech, and consumer services. The firm has built a robust portfolio featuring companies like Whisper Aero, SkyFi, and JOKR, which have shown significant promise in their respective industries. They also have a record of supporting unicorns such as Unit, an open banking solution, and Omio, a platform for booking transportation services globally. Karman Ventures’ investment strategy emphasizes supporting early to growth-stage companies, with an average round size of $31 million. The firm tends to follow rather than lead investment rounds, collaborating with other prominent investors. Despite this, Karman’s network and strategic guidance are pivotal for scaling its portfolio companies, enabling them to grow rapidly within their markets. Karman’s global reach is evident through its diverse portfolio, which includes investments across the US, Europe, and parts of Asia. Karman continues to back companies that demonstrate potential for market disruption and scalability, providing them not only with capital but also strategic expertise drawn from the experience of its founding team and partners. This approach positions Karman Ventures as a dynamic player in the venture capital landscape, blending its roots in tech with a forward-looking investment ethos.

Katalyst Ventures is a multi-stage venture capital firm that focuses on Applied AI across several sectors, including digital health, enterprise SaaS, and autonomous logistics. Founded by Susan Choe, the firm aims to invest in companies that leverage AI to transform analog processes into scalable, data-driven solutions. Their investment philosophy is centered on supporting businesses that can harness predictive algorithms to drive efficiency and innovation across large markets. The firm's portfolio includes notable companies such as Zipline, which uses drone technology for autonomous deliveries, and Arine, a digital health platform optimizing medication management through AI. Katalyst Ventures typically invests from early to growth stages, offering not just capital but strategic support to help startups scale their operations. Their hands-on approach ensures that startups receive guidance on technology, business development, and international expansion. Katalyst's approach to investing in AI-driven businesses reflects a belief in the transformative potential of data and algorithms, akin to previous technological waves like the internet and mobile. With a focus on practical applications that improve everyday operations, they seek to foster startups that can offer borderless, scalable business models.

KAUST Innovation Ventures, the venture capital arm of King Abdullah University of Science and Technology (KAUST), focuses on funding early-stage deep tech startups that address significant scientific and technological challenges. The fund invests in sectors such as energy, environment, food, water, advanced materials, robotics, ICT, and health, aligning closely with KAUST's main research areas. The fund supports startups from seed stages, with investments typically ranging from less than $200,000 to up to $2 million. KAUST Innovation Ventures not only provides financial backing but also strategic support, helping startups transition from research to commercialization through its comprehensive innovation ecosystem, which includes the KAUST Entrepreneurship Center and Technology Transfer Office. Notable startups backed by KAUST include Red Sea Farms, which uses saltwater-tolerant crops to address food security and water scarcity in arid regions, and Sadeem, a company developing multi-patented sensor solutions for flood, traffic, weather, and air quality monitoring​. These investments highlight KAUST's commitment to fostering innovation that has a significant impact on both the local Saudi economy and global markets.

KB Financial Group (KBFG) is a leading financial institution in South Korea, offering a comprehensive range of financial services, including banking, insurance, securities, and asset management. Founded in 2008, KBFG has grown to become a prominent player in the global financial market, with a strong presence in Asia, the United States, Europe, and other regions. The group's investment strategy focuses on diversification and growth across multiple sectors, emphasizing digital transformation and sustainable finance. KBFG is committed to advancing its ESG (Environmental, Social, and Governance) initiatives, integrating these principles into its business operations to promote long-term value creation. KB Financial Group is actively involved in global markets, leveraging its extensive network and resources to drive innovation and expansion. The company is known for its robust governance structure and strategic partnerships, such as its collaboration with The Carlyle Group to enhance its global investment capabilities. With a strong commitment to customer-centric services and a forward-looking approach, KBFG continues to lead the financial services industry in South Korea and beyond.

Korea Biomedical Industry Development Institute (KBIC) is a pivotal entity in South Korea's life sciences and biomedical sectors. Established to stimulate innovation and economic growth, KBIC supports a wide range of activities in medical, pharmaceutical, and biological fields, focusing on advanced technologies like AI and regenerative medicine. KBIC operates through various initiatives and partnerships to foster a robust ecosystem for biomedical research and development. Key areas of focus include promoting bio-health exports, enhancing R&D capabilities, and nurturing talent within the bio-health industry. The South Korean government provides substantial funding and regulatory support to boost the global competitiveness of Korean bio-pharma companies. The institute emphasizes international collaboration, participating in global conventions and establishing partnerships with leading research institutions and biopharmaceutical companies worldwide. This approach enhances innovation and facilitates the entry of Korean companies into the global market.

KB Partners is a Chicago-based venture capital firm that specializes in early-stage investments at the intersection of sports and technology. Founded in 1996 by Keith Bank, the firm has grown into a leading investor in the sports tech sector, building a robust portfolio of companies that leverage innovative technologies to transform the sports, fitness, and wellness landscapes. KB Partners typically invests in startups that bring cutting-edge solutions to the sports market, with initial investments ranging from $1 million to $3 million. They actively participate in the growth of their portfolio companies, offering strategic support, industry expertise, and access to a broad network of connections. Notable companies backed by KB include Full Swing Golf, Hammerhead, and Phenix, all of which are pushing the boundaries of tech integration in sports. The firm’s Myriad Opportunity Fund II, which closed at $127 million, underscores its commitment to scaling early-stage companies. KB Partners takes a hands-on approach, often leading deals and providing follow-on capital to help startups reach their potential. This focus on collaboration is supported by an extensive advisory board that includes industry veterans from major sports leagues and tech companies. With a long-standing presence in the venture capital scene, KB Partners continues to seek out passionate entrepreneurs who are poised to make significant impacts in sports technology, both in the U.S. and beyond.

Focus Fund, based in Belgium, operates as an early-stage venture capital fund managed by KBC Focus Fund and KBC Securities. The fund primarily invests in sectors like nanotechnology, microelectronics, and the Internet of Things (IoT). Focus Fund targets companies that are based not only in Belgium but also across other European countries, including France, Germany, and the Netherlands. The fund is known for its strategic investments in high-tech startups, with initial investments typically ranging from €500,000 to €3 million. Some of the notable companies in their portfolio include E-peas and Micledi, both of which are involved in advanced semiconductor technologies. The fund emphasizes supporting companies that develop cutting-edge technologies with the potential for significant market impact. The leadership at Focus Fund, including key figures like Isabelle Cardinael and Rudi Severijns, brings extensive experience in both venture capital and technology investments, guiding the fund's strategic decisions and portfolio management​.

Koch Disruptive Technologies is a venture capital firm within Koch Industries, focused on investing in transformative companies across various stages and industries. KDT partners with innovative companies that leverage advanced technologies to create significant economic and societal impacts. The firm’s investment strategy is sector-agnostic, including notable areas like biotechnology, health tech, agriculture, and AI. Some prominent companies in their portfolio include PathAI, which improves pathology diagnostics using AI, and Solugen, which creates environmentally-friendly chemicals through enzymatic reactions. Other investments include Terray Therapeutics, focusing on novel treatments for human diseases, and Andes, which develops bio-based agricultural solutions to enhance crop production. KDT provides more than just financial backing. They offer strategic guidance and leverage Koch Industries’ extensive network to help portfolio companies scale and succeed. The team at KDT includes professionals with diverse expertise, providing valuable support in navigating market challenges and accelerating growth.